This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Centro De Inmunologia Molecular. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Victor Brito Navarro: Innovator in Biotechnology
Introduction
Victor Brito Navarro is a notable inventor based in Havana, Cuba. He has made significant contributions to the field of biotechnology, particularly in the development of new products aimed at improving human health. His work focuses on creating specific monoclonal antibodies that have important applications in diagnosing and treating cardiovascular diseases.
Latest Patents
Victor Brito Navarro holds a patent for "Anti sulfatides and anti sulfated proteoglycans antibodies and their use." This invention provides new specific monoclonal antibodies that bind with high affinity to sulfatides and sulfated proteoglycans. The antibodies disclosed in this patent serve as important diagnostic and therapeutic tools for addressing pathological processes associated with atherosclerotic plaques. The invention also includes pharmaceutical compositions comprising these monoclonal antibodies or their fragments for therapeutic and diagnostic use related to cardiovascular diseases.
Career Highlights
Victor Brito Navarro is affiliated with the Centro de Inmunología Molecular, where he continues to advance his research in biotechnology. His innovative work has the potential to significantly impact the medical field, particularly in the diagnosis and treatment of cardiovascular conditions.
Collaborations
Some of his notable coworkers include Ana Maria Vazquez Lopez and Alejandro Lopez Requena. Their collaborative efforts contribute to the ongoing research and development in the field of biotechnology.
Conclusion
Victor Brito Navarro is a pioneering inventor whose work in biotechnology is paving the way for new diagnostic and therapeutic solutions in human health. His contributions are vital for advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile